Kimberly Stegmaier, MD
Chair of the Department of Pediatric Oncology, Dana-Farber Cancer Institute
Associate Chief, Division of Hematology/Oncology, Boston Children’s Hospital
David G. Nathan Professor of Pediatrics, Harvard Medical School
Institute Member, Broad Institute of Harvard and MIT
Kimberly Stegmaier, MD, received her undergraduate degree from Duke University, medical degree from Harvard Medical School (HMS), and trained in Pediatrics and Pediatric Hematology/Oncology at Boston Children’s Hospital (BCH) and Dana-Farber Cancer Institute (DFCI). She has been a faculty member at DFCI, BCH, and HMS since 2002 and an independent investigator since 2006.
Dr. Stegmaier is dedicated to the goal of precision pediatric oncology medicine, pioneering the development and application of innovative genomic approaches to identify new therapies for childhood cancer. She has focused her efforts on acute leukemias and pediatric solid tumors, particularly those driven by fusion oncoproteins. The Stegmaier lab has discovered novel technologies, concepts, and targets with translational impact.
Dr. Stegmaier is motivated by the magic of discovery, particularly discoveries with the potential to impact patients. A pediatrician at heart, she also enjoys watching her lab members develop and grow into their careers. Outside of the lab, Dr. Stegmaier loves ballet. She danced with the Ballet Theater of Boston during medical school and still takes ballet classes regularly.